Flavonoids in treatment of chronic kidney disease

Chronic kidney disease (CKD) is a progressive systemic disease, which changes the function and structure of the kidneys irreversibly over months or years. The final common pathological manifestation of chronic kidney disease is renal fibrosis and is characterized by glomerulosclerosis, tubular atrop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Cao, Yi-Ling (VerfasserIn) , Lin, Jihong (VerfasserIn) , Hammes, Hans-Peter (VerfasserIn) , Zhang, Chun (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 April 2022
In: Molecules
Year: 2022, Jahrgang: 27, Heft: 7, Pages: 1-23
ISSN:1420-3049
DOI:10.3390/molecules27072365
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/molecules27072365
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1420-3049/27/7/2365
Volltext
Verfasserangaben:Yi-Ling Cao, Ji-Hong Lin, Hans-Peter Hammes and Chun Zhang

MARC

LEADER 00000caa a2200000 c 4500
001 1806869829
003 DE-627
005 20230427160805.0
007 cr uuu---uuuuu
008 220613s2022 xx |||||o 00| ||eng c
024 7 |a 10.3390/molecules27072365  |2 doi 
035 |a (DE-627)1806869829 
035 |a (DE-599)KXP1806869829 
035 |a (OCoLC)1341461349 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Cao, Yi-Ling  |e VerfasserIn  |0 (DE-588)1259766179  |0 (DE-627)1806869381  |4 aut 
245 1 0 |a Flavonoids in treatment of chronic kidney disease  |c Yi-Ling Cao, Ji-Hong Lin, Hans-Peter Hammes and Chun Zhang 
264 1 |c 6 April 2022 
300 |a 23 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: 6 April 2022 
500 |a Gesehen am 13.06.2022 
520 |a Chronic kidney disease (CKD) is a progressive systemic disease, which changes the function and structure of the kidneys irreversibly over months or years. The final common pathological manifestation of chronic kidney disease is renal fibrosis and is characterized by glomerulosclerosis, tubular atrophy, and interstitial fibrosis. In recent years, numerous studies have reported the therapeutic benefits of natural products against modern diseases. Substantial attention has been focused on the biological role of polyphenols, in particular flavonoids, presenting broadly in plants and diets, referring to thousands of plant compounds with a common basic structure. Evidence-based pharmacological data have shown that flavonoids play an important role in preventing and managing CKD and renal fibrosis. These compounds can prevent renal dysfunction and improve renal function by blocking or suppressing deleterious pathways such as oxidative stress and inflammation. In this review, we summarize the function and beneficial properties of common flavonoids for the treatment of CKD and the relative risk factors of CKD. 
650 4 |a chronic kidney disease 
650 4 |a flavonoids 
650 4 |a inflammation 
650 4 |a nephroprotection 
650 4 |a oxidative stress 
700 1 |a Lin, Jihong  |d 1962-  |e VerfasserIn  |0 (DE-588)130655554  |0 (DE-627)505290995  |0 (DE-576)298325020  |4 aut 
700 1 |a Hammes, Hans-Peter  |d 1955-  |e VerfasserIn  |0 (DE-588)102028353X  |0 (DE-627)691169772  |0 (DE-576)360007252  |4 aut 
700 1 |a Zhang, Chun  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecules  |d Basel : MDPI, 1996  |g 27(2022), 7, Artikel-ID 2365, Seite 1-23  |h Online-Ressource  |w (DE-627)311313132  |w (DE-600)2008644-1  |w (DE-576)281192456  |x 1420-3049  |7 nnas  |a Flavonoids in treatment of chronic kidney disease 
773 1 8 |g volume:27  |g year:2022  |g number:7  |g elocationid:2365  |g pages:1-23  |g extent:23  |a Flavonoids in treatment of chronic kidney disease 
856 4 0 |u https://doi.org/10.3390/molecules27072365  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1420-3049/27/7/2365  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220613 
993 |a Article 
994 |a 2022 
998 |g 102028353X  |a Hammes, Hans-Peter  |m 102028353X:Hammes, Hans-Peter  |d 60000  |d 61400  |e 60000PH102028353X  |e 61400PH102028353X  |k 0/60000/  |k 1/60000/61400/  |p 2 
998 |g 130655554  |a Lin, Jihong  |m 130655554:Lin, Jihong  |d 60000  |d 61400  |e 60000PL130655554  |e 61400PL130655554  |k 0/60000/  |k 1/60000/61400/  |p 1  |x j 
999 |a KXP-PPN1806869829  |e 4149055386 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Cao","display":"Cao, Yi-Ling","role":"aut","given":"Yi-Ling"},{"role":"aut","given":"Jihong","family":"Lin","display":"Lin, Jihong"},{"role":"aut","given":"Hans-Peter","display":"Hammes, Hans-Peter","family":"Hammes"},{"given":"Chun","role":"aut","family":"Zhang","display":"Zhang, Chun"}],"language":["eng"],"note":["Published: 6 April 2022","Gesehen am 13.06.2022"],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"6 April 2022"}],"title":[{"title":"Flavonoids in treatment of chronic kidney disease","title_sort":"Flavonoids in treatment of chronic kidney disease"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1806869829","relHost":[{"language":["eng"],"part":{"year":"2022","pages":"1-23","issue":"7","text":"27(2022), 7, Artikel-ID 2365, Seite 1-23","extent":"23","volume":"27"},"title":[{"subtitle":"a journal of synthetic chemistry and natural product chemistry","title_sort":"Molecules","title":"Molecules"}],"origin":[{"publisher":"MDPI","dateIssuedKey":"1996","dateIssuedDisp":"1996-","publisherPlace":"Basel"}],"note":["Gesehen am 25.06.20"],"pubHistory":["1.1996 -"],"disp":"Flavonoids in treatment of chronic kidney diseaseMolecules","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"311313132","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Molecular Diversity Preservation International"]},"id":{"eki":["311313132"],"issn":["1420-3049"],"zdb":["2008644-1"]}}],"name":{"displayForm":["Yi-Ling Cao, Ji-Hong Lin, Hans-Peter Hammes and Chun Zhang"]},"physDesc":[{"extent":"23 S."}],"id":{"eki":["1806869829"],"doi":["10.3390/molecules27072365"]}} 
SRT |a CAOYILINGLFLAVONOIDS6202